Industry Research Reports

Home > Reports > Chemical & Material > Global Benfotiamine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Benfotiamine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Chemical & Material

Published Date: 2025-02-24

Pages: 94 Pages

Report ld: 4201495

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Benfotiamine market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Benfotiamine is a lab-made version of vitamin B1, also called thiamine. Scientists are studying it to see if it might help conditions like diabetes-related nerve damage, Alzheimer"s disease, and alcohol dependence.

The North America Benfotiamine market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.

The global key manufacturers of Benfotiamine include Klaire, Hamari, BioXera Pharma, Kimia Biosciences, AOR, Country Life Vitamins, Neurohacker Collective, XY Mogen, Pharmaffiliates, Hangzhou Eastbiopharm, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.

In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.

The global Benfotiamine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Benfotiamine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

MARKET SEGMENTATION

By Company

Klaire
Hamari
BioXera Pharma
Kimia Biosciences
AOR
Country Life Vitamins
Neurohacker Collective
XY Mogen
Pharmaffiliates
Hangzhou Eastbiopharm
Basil Pharmaceuticals
Ami Lifesciences
Kaival Chemicals

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Pharma Grade
Food Grade

Segment by Application

DietarySupplement
Diabetic Neuropathy
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales and revenue of Benfotiamine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.

Chapter 3: Detailed analysis of Benfotiamine manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Benfotiamine revenue, gross margin, and recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Sales channels analysis

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Benfotiamine Product Scope

1.2 Benfotiamine by Type

1.2.1 Global Benfotiamine Sales by Type (2020 & 2024 & 2031)

1.2.2 Pharma Grade

1.2.3 Food Grade

1.3 Benfotiamine by Application

1.3.1 Global Benfotiamine Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 DietarySupplement

1.3.3 Diabetic Neuropathy

1.3.4 Others

1.4 Global Benfotiamine Market Estimates and Forecasts (2020-2031)

1.4.1 Global Benfotiamine Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Benfotiamine Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Benfotiamine Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Benfotiamine Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Benfotiamine Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Benfotiamine Sales Market Share by Region (2020-2025)

2.2.2 Global Benfotiamine Revenue Market Share by Region (2020-2025)

2.3 Global Benfotiamine Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Benfotiamine Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Benfotiamine Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Benfotiamine Market Size and Prospective (2020-2031)

2.4.2 Europe Benfotiamine Market Size and Prospective (2020-2031)

2.4.3 China Benfotiamine Market Size and Prospective (2020-2031)

2.4.4 Japan Benfotiamine Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Benfotiamine Historic Market Review by Type (2020-2025)

3.1.1 Global Benfotiamine Sales by Type (2020-2025)

3.1.2 Global Benfotiamine Revenue by Type (2020-2025)

3.1.3 Global Benfotiamine Price by Type (2020-2025)

3.2 Global Benfotiamine Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Benfotiamine Sales Forecast by Type (2026-2031)

3.2.2 Global Benfotiamine Revenue Forecast by Type (2026-2031)

3.2.3 Global Benfotiamine Price Forecast by Type (2026-2031)

3.3 Different Types Benfotiamine Representative Players

4 Global Market Size by Application

4.1 Global Benfotiamine Historic Market Review by Application (2020-2025)

4.1.1 Global Benfotiamine Sales by Application (2020-2025)

4.1.2 Global Benfotiamine Revenue by Application (2020-2025)

4.1.3 Global Benfotiamine Price by Application (2020-2025)

4.2 Global Benfotiamine Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Benfotiamine Sales Forecast by Application (2026-2031)

4.2.2 Global Benfotiamine Revenue Forecast by Application (2026-2031)

4.2.3 Global Benfotiamine Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Benfotiamine Application

5 Competition Landscape by Players

5.1 Global Benfotiamine Sales by Players (2020-2025)

5.2 Global Top Benfotiamine Players by Revenue (2020-2025)

5.3 Global Benfotiamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benfotiamine as of 2024)

5.4 Global Benfotiamine Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Benfotiamine, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Benfotiamine, Product Type & Application

5.7 Global Key Manufacturers of Benfotiamine, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Benfotiamine Sales by Company

6.1.1.1 North America Benfotiamine Sales by Company (2020-2025)

6.1.1.2 North America Benfotiamine Revenue by Company (2020-2025)

6.1.2 North America Benfotiamine Sales Breakdown by Type (2020-2025)

6.1.3 North America Benfotiamine Sales Breakdown by Application (2020-2025)

6.1.4 North America Benfotiamine Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Benfotiamine Sales by Company

6.2.1.1 Europe Benfotiamine Sales by Company (2020-2025)

6.2.1.2 Europe Benfotiamine Revenue by Company (2020-2025)

6.2.2 Europe Benfotiamine Sales Breakdown by Type (2020-2025)

6.2.3 Europe Benfotiamine Sales Breakdown by Application (2020-2025)

6.2.4 Europe Benfotiamine Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Benfotiamine Sales by Company

6.3.1.1 China Benfotiamine Sales by Company (2020-2025)

6.3.1.2 China Benfotiamine Revenue by Company (2020-2025)

6.3.2 China Benfotiamine Sales Breakdown by Type (2020-2025)

6.3.3 China Benfotiamine Sales Breakdown by Application (2020-2025)

6.3.4 China Benfotiamine Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Benfotiamine Sales by Company

6.4.1.1 Japan Benfotiamine Sales by Company (2020-2025)

6.4.1.2 Japan Benfotiamine Revenue by Company (2020-2025)

6.4.2 Japan Benfotiamine Sales Breakdown by Type (2020-2025)

6.4.3 Japan Benfotiamine Sales Breakdown by Application (2020-2025)

6.4.4 Japan Benfotiamine Major Customer

6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Klaire

7.1.1 Klaire Company Information

7.1.2 Klaire Business Overview

7.1.3 Klaire Benfotiamine Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Klaire Benfotiamine Products Offered

7.1.5 Klaire Recent Development

7.2 Hamari

7.2.1 Hamari Company Information

7.2.2 Hamari Business Overview

7.2.3 Hamari Benfotiamine Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Hamari Benfotiamine Products Offered

7.2.5 Hamari Recent Development

7.3 BioXera Pharma

7.3.1 BioXera Pharma Company Information

7.3.2 BioXera Pharma Business Overview

7.3.3 BioXera Pharma Benfotiamine Sales, Revenue and Gross Margin (2020-2025)

7.3.4 BioXera Pharma Benfotiamine Products Offered

7.3.5 BioXera Pharma Recent Development

7.4 Kimia Biosciences

7.4.1 Kimia Biosciences Company Information

7.4.2 Kimia Biosciences Business Overview

7.4.3 Kimia Biosciences Benfotiamine Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Kimia Biosciences Benfotiamine Products Offered

7.4.5 Kimia Biosciences Recent Development

7.5 AOR

7.5.1 AOR Company Information

7.5.2 AOR Business Overview

7.5.3 AOR Benfotiamine Sales, Revenue and Gross Margin (2020-2025)

7.5.4 AOR Benfotiamine Products Offered

7.5.5 AOR Recent Development

7.6 Country Life Vitamins

7.6.1 Country Life Vitamins Company Information

7.6.2 Country Life Vitamins Business Overview

7.6.3 Country Life Vitamins Benfotiamine Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Country Life Vitamins Benfotiamine Products Offered

7.6.5 Country Life Vitamins Recent Development

7.7 Neurohacker Collective

7.7.1 Neurohacker Collective Company Information

7.7.2 Neurohacker Collective Business Overview

7.7.3 Neurohacker Collective Benfotiamine Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Neurohacker Collective Benfotiamine Products Offered

7.7.5 Neurohacker Collective Recent Development

7.8 XY Mogen

7.8.1 XY Mogen Company Information

7.8.2 XY Mogen Business Overview

7.8.3 XY Mogen Benfotiamine Sales, Revenue and Gross Margin (2020-2025)

7.8.4 XY Mogen Benfotiamine Products Offered

7.8.5 XY Mogen Recent Development

7.9 Pharmaffiliates

7.9.1 Pharmaffiliates Company Information

7.9.2 Pharmaffiliates Business Overview

7.9.3 Pharmaffiliates Benfotiamine Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Pharmaffiliates Benfotiamine Products Offered

7.9.5 Pharmaffiliates Recent Development

7.10 Hangzhou Eastbiopharm

7.10.1 Hangzhou Eastbiopharm Company Information

7.10.2 Hangzhou Eastbiopharm Business Overview

7.10.3 Hangzhou Eastbiopharm Benfotiamine Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Hangzhou Eastbiopharm Benfotiamine Products Offered

7.10.5 Hangzhou Eastbiopharm Recent Development

7.11 Basil Pharmaceuticals

7.11.1 Basil Pharmaceuticals Company Information

7.11.2 Basil Pharmaceuticals Business Overview

7.11.3 Basil Pharmaceuticals Benfotiamine Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Basil Pharmaceuticals Benfotiamine Products Offered

7.11.5 Basil Pharmaceuticals Recent Development

7.12 Ami Lifesciences

7.12.1 Ami Lifesciences Company Information

7.12.2 Ami Lifesciences Business Overview

7.12.3 Ami Lifesciences Benfotiamine Sales, Revenue and Gross Margin (2020-2025)

7.12.4 Ami Lifesciences Benfotiamine Products Offered

7.12.5 Ami Lifesciences Recent Development

7.13 Kaival Chemicals

7.13.1 Kaival Chemicals Company Information

7.13.2 Kaival Chemicals Business Overview

7.13.3 Kaival Chemicals Benfotiamine Sales, Revenue and Gross Margin (2020-2025)

7.13.4 Kaival Chemicals Benfotiamine Products Offered

7.13.5 Kaival Chemicals Recent Development

8 Benfotiamine Manufacturing Cost Analysis

8.1 Benfotiamine Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Benfotiamine

8.4 Benfotiamine Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Benfotiamine Distributors List

9.3 Benfotiamine Customers

10 Benfotiamine Market Dynamics

10.1 Benfotiamine Industry Trends

10.2 Benfotiamine Market Drivers

10.3 Benfotiamine Market Challenges

10.4 Benfotiamine Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Benfotiamine Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Benfotiamine Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Benfotiamine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Benfotiamine Sales (K MT) by Region (2020-2025)

Table 5. Global Benfotiamine Sales Market Share by Region (2020-2025)

Table 6. Global Benfotiamine Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Benfotiamine Revenue Share by Region (2020-2025)

Table 8. Global Benfotiamine Sales (K MT) Forecast by Region (2026-2031)

Table 9. Global Benfotiamine Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Benfotiamine Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Benfotiamine Revenue Share Forecast by Region (2026-2031)

Table 12. Global Benfotiamine Sales by Type (K MT) & (2020-2025)

Table 13. Global Benfotiamine Sales Share by Type (2020-2025)

Table 14. Global Benfotiamine Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Benfotiamine Price by Type (USD/MT) & (2020-2025)

Table 16. Global Benfotiamine Sales by Type (K MT) & (2026-2031)

Table 17. Global Benfotiamine Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Benfotiamine Price by Type (USD/MT) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Benfotiamine Sales by Application (K MT) & (2020-2025)

Table 21. Global Benfotiamine Sales Share by Application (2020-2025)

Table 22. Global Benfotiamine Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Benfotiamine Price by Application (USD/MT) & (2020-2025)

Table 24. Global Benfotiamine Sales by Application (K MT) & (2026-2031)

Table 25. Global Benfotiamine Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Benfotiamine Price by Application (USD/MT) & (2026-2031)

Table 27. New Sources of Growth in Benfotiamine Application

Table 28. Global Benfotiamine Sales by Company (K MT) & (2020-2025)

Table 29. Global Benfotiamine Sales Share by Company (2020-2025)

Table 30. Global Benfotiamine Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Benfotiamine Revenue Share by Company (2020-2025)

Table 32. Global Benfotiamine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benfotiamine as of 2024)

Table 33. Global Market Benfotiamine Average Price by Company (USD/MT) & (2020-2025)

Table 34. Global Key Manufacturers of Benfotiamine, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Benfotiamine, Product Type & Application

Table 36. Global Key Manufacturers of Benfotiamine, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Benfotiamine Sales by Company (2020-2025) & (K MT)

Table 39. North America Benfotiamine Sales Market Share by Company (2020-2025)

Table 40. North America Benfotiamine Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Benfotiamine Revenue Market Share by Company (2020-2025)

Table 42. North America Benfotiamine Sales by Type (2020-2025) & (K MT)

Table 43. North America Benfotiamine Sales Market Share by Type (2020-2025)

Table 44. North America Benfotiamine Sales by Application (2020-2025) & (K MT)

Table 45. North America Benfotiamine Sales Market Share by Application (2020-2025)

Table 46. Europe Benfotiamine Sales by Company (2020-2025) & (K MT)

Table 47. Europe Benfotiamine Sales Market Share by Company (2020-2025)

Table 48. Europe Benfotiamine Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Benfotiamine Revenue Market Share by Company (2020-2025)

Table 50. Europe Benfotiamine Sales by Type (2020-2025) & (K MT)

Table 51. Europe Benfotiamine Sales Market Share by Type (2020-2025)

Table 52. Europe Benfotiamine Sales by Application (2020-2025) & (K MT)

Table 53. Europe Benfotiamine Sales Market Share by Application (2020-2025)

Table 54. China Benfotiamine Sales by Company (2020-2025) & (K MT)

Table 55. China Benfotiamine Sales Market Share by Company (2020-2025)

Table 56. China Benfotiamine Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Benfotiamine Revenue Market Share by Company (2020-2025)

Table 58. China Benfotiamine Sales by Type (2020-2025) & (K MT)

Table 59. China Benfotiamine Sales Market Share by Type (2020-2025)

Table 60. China Benfotiamine Sales by Application (2020-2025) & (K MT)

Table 61. China Benfotiamine Sales Market Share by Application (2020-2025)

Table 62. Japan Benfotiamine Sales by Company (2020-2025) & (K MT)

Table 63. Japan Benfotiamine Sales Market Share by Company (2020-2025)

Table 64. Japan Benfotiamine Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Benfotiamine Revenue Market Share by Company (2020-2025)

Table 66. Japan Benfotiamine Sales by Type (2020-2025) & (K MT)

Table 67. Japan Benfotiamine Sales Market Share by Type (2020-2025)

Table 68. Japan Benfotiamine Sales by Application (2020-2025) & (K MT)

Table 69. Japan Benfotiamine Sales Market Share by Application (2020-2025)

Table 70. Klaire Company Information

Table 71. Klaire Description and Business Overview

Table 72. Klaire Benfotiamine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 73. Klaire Benfotiamine Product

Table 74. Klaire Recent Development

Table 75. Hamari Company Information

Table 76. Hamari Description and Business Overview

Table 77. Hamari Benfotiamine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 78. Hamari Benfotiamine Product

Table 79. Hamari Recent Development

Table 80. BioXera Pharma Company Information

Table 81. BioXera Pharma Description and Business Overview

Table 82. BioXera Pharma Benfotiamine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 83. BioXera Pharma Benfotiamine Product

Table 84. BioXera Pharma Recent Development

Table 85. Kimia Biosciences Company Information

Table 86. Kimia Biosciences Description and Business Overview

Table 87. Kimia Biosciences Benfotiamine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 88. Kimia Biosciences Benfotiamine Product

Table 89. Kimia Biosciences Recent Development

Table 90. AOR Company Information

Table 91. AOR Description and Business Overview

Table 92. AOR Benfotiamine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 93. AOR Benfotiamine Product

Table 94. AOR Recent Development

Table 95. Country Life Vitamins Company Information

Table 96. Country Life Vitamins Description and Business Overview

Table 97. Country Life Vitamins Benfotiamine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 98. Country Life Vitamins Benfotiamine Product

Table 99. Country Life Vitamins Recent Development

Table 100. Neurohacker Collective Company Information

Table 101. Neurohacker Collective Description and Business Overview

Table 102. Neurohacker Collective Benfotiamine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 103. Neurohacker Collective Benfotiamine Product

Table 104. Neurohacker Collective Recent Development

Table 105. XY Mogen Company Information

Table 106. XY Mogen Description and Business Overview

Table 107. XY Mogen Benfotiamine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 108. XY Mogen Benfotiamine Product

Table 109. XY Mogen Recent Development

Table 110. Pharmaffiliates Company Information

Table 111. Pharmaffiliates Description and Business Overview

Table 112. Pharmaffiliates Benfotiamine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 113. Pharmaffiliates Benfotiamine Product

Table 114. Pharmaffiliates Recent Development

Table 115. Hangzhou Eastbiopharm Company Information

Table 116. Hangzhou Eastbiopharm Description and Business Overview

Table 117. Hangzhou Eastbiopharm Benfotiamine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 118. Hangzhou Eastbiopharm Benfotiamine Product

Table 119. Hangzhou Eastbiopharm Recent Development

Table 120. Basil Pharmaceuticals Company Information

Table 121. Basil Pharmaceuticals Description and Business Overview

Table 122. Basil Pharmaceuticals Benfotiamine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 123. Basil Pharmaceuticals Benfotiamine Product

Table 124. Basil Pharmaceuticals Recent Development

Table 125. Ami Lifesciences Company Information

Table 126. Ami Lifesciences Description and Business Overview

Table 127. Ami Lifesciences Benfotiamine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 128. Ami Lifesciences Benfotiamine Product

Table 129. Ami Lifesciences Recent Development

Table 130. Kaival Chemicals Company Information

Table 131. Kaival Chemicals Description and Business Overview

Table 132. Kaival Chemicals Benfotiamine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)

Table 133. Kaival Chemicals Benfotiamine Product

Table 134. Kaival Chemicals Recent Development

Table 135. Production Base and Market Concentration Rate of Raw Material

Table 136. Key Suppliers of Raw Materials

Table 137. Benfotiamine Distributors List

Table 138. Benfotiamine Customers List

Table 139. Benfotiamine Market Trends

Table 140. Benfotiamine Market Drivers

Table 141. Benfotiamine Market Challenges

Table 142. Benfotiamine Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Benfotiamine Product Picture

Figure 2. Global Benfotiamine Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Benfotiamine Sales Market Share by Type in 2024 & 2031

Figure 4. Pharma Grade Product Picture

Figure 5. Food Grade Product Picture

Figure 6. Global Benfotiamine Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Benfotiamine Sales Market Share by Application in 2024 & 2031

Figure 8. DietarySupplement Examples

Figure 9. Diabetic Neuropathy Examples

Figure 10. Others Examples

Figure 11. Global Benfotiamine Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Benfotiamine Sales Growth Rate (2020-2031) & (US$ Million)

Figure 13. Global Benfotiamine Sales (K MT) Growth Rate (2020-2031)

Figure 14. Global Benfotiamine Price Trends Growth Rate (2020-2031) & (USD/MT)

Figure 15. Benfotiamine Report Years Considered

Figure 16. Global Market Benfotiamine Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 17. Global Benfotiamine Revenue Market Share by Region: 2020 VS 2024

Figure 18. North America Benfotiamine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. North America Benfotiamine Sales (K MT) Growth Rate (2020-2031)

Figure 20. Europe Benfotiamine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Europe Benfotiamine Sales (K MT) Growth Rate (2020-2031)

Figure 22. China Benfotiamine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. China Benfotiamine Sales (K MT) Growth Rate (2020-2031)

Figure 24. Japan Benfotiamine Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. Japan Benfotiamine Sales (K MT) Growth Rate (2020-2031)

Figure 26. Global Benfotiamine Revenue Share by Type (2020-2025)

Figure 27. Global Benfotiamine Sales Share by Type (2026-2031)

Figure 28. Global Benfotiamine Revenue Share by Type (2026-2031)

Figure 29. Global Benfotiamine Revenue Share by Application (2020-2025)

Figure 30. Global Benfotiamine Revenue Growth Rate by Application in 2020 & 2024

Figure 31. Global Benfotiamine Sales Share by Application (2026-2031)

Figure 32. Global Benfotiamine Revenue Share by Application (2026-2031)

Figure 33. Global Benfotiamine Sales Share by Company (2024)

Figure 34. Global Benfotiamine Revenue Share by Company (2024)

Figure 35. Global 5 Largest Benfotiamine Players Market Share by Revenue in Benfotiamine: 2020 & 2024

Figure 36. Benfotiamine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 37. Manufacturing Cost Structure of Benfotiamine

Figure 38. Manufacturing Process Analysis of Benfotiamine

Figure 39. Benfotiamine Industrial Chain

Figure 40. Channels of Distribution (Direct Vs Distribution)

Figure 41. Distributors Profiles

Figure 42. Bottom-up and Top-down Approaches for This Report

Figure 43. Data Triangulation

Figure 44. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Benfotiamine market? zhanKai

The top companies in the global Benfotiamine market are Klaire、Hamari、BioXera Pharma.

Related Reports

Benfotiamine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Benfotiamine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-15
Pages: 138
USD 3950.00
(Single User License)
Global Benfotiamine Market Research Report 2026
The global Benfotiamine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-28
Pages: 144
USD 2900.00
(Single User License)
Global Benfotiamine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Benfotiamine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 151
USD 4900.00
(Single User License)
Global Benfotiamine Market Research Report 2025
The global market for Benfotiamine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 105
USD 2900.00
(Single User License)
Benfotiamine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Benfotiamine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 123
USD 3950.00
(Single User License)
Global Benfotiamine Market Insights, Forecast to 2030
Benfotiamine is a lab-made version of vitamin B1, also called thiamine. Scientists are studying it to see if it might help conditions like diabetes-related nerve damage, Alzheimer's disease, and alcohol dependence.
Published Date: 2024-04-22
Pages: 109
USD 4900.00
(Single User License)
Global Benfotiamine Market Research Report 2024
Benfotiamine is a lab-made version of vitamin B1, also called thiamine. Scientists are studying it to see if it might help conditions like diabetes-related nerve damage, Alzheimer's disease, and alcohol dependence.
Published Date: 2024-01-05
Pages: 97
USD 2900.00
(Single User License)

Benfotiamine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Benfotiamine was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-15
Pages: 138
USD 3950.00 (Single User License)
Global Benfotiamine Market Research Report 2026
The global Benfotiamine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-28
Pages: 144
USD 2900.00 (Single User License)
Global Benfotiamine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Benfotiamine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 151
USD 4900.00 (Single User License)
Global Benfotiamine Market Research Report 2025
The global market for Benfotiamine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 105
USD 2900.00 (Single User License)
Benfotiamine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Benfotiamine was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 123
USD 3950.00 (Single User License)
Global Benfotiamine Market Insights, Forecast to 2030
Benfotiamine is a lab-made version of vitamin B1, also called thiamine. Scientists are studying it to see if it might help conditions like diabetes-related nerve damage, Alzheimer's disease, and alcohol dependence.
Published: 2024-04-22
Pages: 109
USD 4900.00 (Single User License)
Global Benfotiamine Market Research Report 2024
Benfotiamine is a lab-made version of vitamin B1, also called thiamine. Scientists are studying it to see if it might help conditions like diabetes-related nerve damage, Alzheimer's disease, and alcohol dependence.
Published: 2024-01-05
Pages: 97
USD 2900.00 (Single User License)